Showing results (1-10 of 186) with videos related to
Sort By:
Pageof 19
Endocrine Reviews|February 20, 2026
Steroid Receptor Coactivators - From Basic Research to Translational OpportunitiesYosef Gilad, Sang Jun Han, David M LonardThe Journal of Biological Chemistry|April 29, 2026
Steroid Receptor Coactivators in Immunity - From Function to Emerging Translational OpportunitiesYosef Gilad, David M LonardJournal of Leukocyte Biology|November 9, 2025
Method for generation and ex vivo expansion of genetically edited mouse TregsYosef Gilad, Adam M Dean, Yan Xia, et al.Trends in Endocrinology and Metabolism: TEM|November 21, 2008
Multi-modulation of nuclear receptor coactivators through posttranslational modificationsSang Jun Han, David M Lonard, Bert W O'MalleyOncoimmunology|March 3, 2026
Steroid receptor coactivator 3-deficient regulatory T cells eradicate multiple solid tumors in syngeneic mouse modelsNuri Sung, Eunsu Kim, Yosef Gilad, et al.Frontiers in Immunology|May 3, 2024
Steroid receptor coactivators in Treg and Th17 cell biology and functionYosi Gilad, Ortal Shimon, Sang Jun Han, et al.Breast Cancer Research : BCR|November 1, 2022
Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironmentSang Jun Han, Nuri Sung, Jin Wang, et al.Biorxiv : the Preprint Server for Biology|April 10, 2023
Steroid Receptor Coactivator-3 is a Key Modulator of Regulatory T Cell-Mediated Tumor EvasionSang Jun Han, Prashi Jain, Yosef Gilad, et al.Proceedings of the National Academy of Sciences of the United States of America|May 30, 2023
Steroid receptor coactivator 3 is a key modulator of regulatory T cell-mediated tumor evasionSang Jun Han, Prashi Jain, Yosef Gilad, et al.Scientific Reports|March 6, 2020
Author Correction: Drug-induced PD-L1 expression and cell stress response in breast cancer cells can be balanced by drug combinationYosi Gilad, Yossi Eliaz, Yang Yu, et al.Pageof 19